Several alterations can contribute to gliomagenesis, including isocitrate dehydrogenase mutation (IDH-1), alpha-thalassemia/mental retardation, X-linked mutation (ATRX), and tumor protein p53 mutation (TP53). Here, TP53 is linked to alpha thalassemia spectrum.